Genetically engineered proteins for immunoregulation.
D036002:ADP Ribose Transferases; D000818:Animals; D000911:Antibodies, Monoclonal; D001427:Bacterial Toxins; D005098:Exotoxins / Q000627:therapeutic use; D005818:Genetic Engineering; D006801:Humans; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D007142:Immunoglobulin gamma-Chains; D007165:Immunosuppression Therapy / Q000379:methods*; D000922:Immunotoxins / Q000627:therapeutic use*; D051379:Mice; D011065:Poly(ADP-ribose) Polymerases / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D000911:Antibodies, Monoclonal; D001427:Bacterial Toxins; D005098:Exotoxins; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D007142:Immunoglobulin gamma-Chains; D000922:Immunotoxins; D011065:Poly(ADP-ribose) Polymerases; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A